Historique
Bulletin de Périodique
Journal of Analytical Toxicology , Vol.50, n°3 - March 2026
Paru le :
01/03/2026
Année
2026
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- The acute and chronic pharmacokinetic oral fluid profile of oral cannabidiol (CBD) with and without low doses of delta-9-tetrahydrocannabinol (Δ9-THC) in healthy human volunteers. Vikingsson S., Zamarripa C.A., Spindle T.R., Klausner M., Wolinsky D., Cone E.J., et al., art. bkaf102.
- Pharmacokinetic study of delta-8-tetrahydrocannabinol in male rats using a validated bioanalytical method. Senetra A.S., Mukhopadhyay S., Chiang Y.-H., Kuntz M.A., Kanumuri S.R.R., Zequeira S., et al., art. bkaf105.
- Pre-analytical stability of drugs of abuse in urine for confirmatory testing: a systematic review. Hoffmann-Lücke E., Steffensen E.H., Samson M., Greibe E., art. bkaf106.
- The rise of nitrous oxide in toxicological casework: no laughing matter. D'Orazio A.L., Bierly J.J., Midthun K.M., art. bkaf108.
- 4-Anilino-N-phenylethylpiperidine (4-ANPP): the potential caution flag for illicit fentanyl. Laraia N., Bierly J.J., Chan-Hosokawa A., art. bkaf111.
- Validation of a microsampling-compatible liquid–liquid extraction method for cannabinoid quantitation in 50 µL of whole blood using liquid chromatography–mass spectrometry. Mohammed A.A., Khan M., Chan H., Brubacher J.R., art. bkag004.
- The acute and chronic pharmacokinetic oral fluid profile of oral cannabidiol (CBD) with and without low doses of delta-9-tetrahydrocannabinol (Δ9-THC) in healthy human volunteers. Vikingsson S., Zamarripa C.A., Spindle T.R., Klausner M., Wolinsky D., Cone E.J., et al., art. bkaf102.
- Pharmacokinetic study of delta-8-tetrahydrocannabinol in male rats using a validated bioanalytical method. Senetra A.S., Mukhopadhyay S., Chiang Y.-H., Kuntz M.A., Kanumuri S.R.R., Zequeira S., et al., art. bkaf105.
- Pre-analytical stability of drugs of abuse in urine for confirmatory testing: a systematic review. Hoffmann-Lücke E., Steffensen E.H., Samson M., Greibe E., art. bkaf106.
- The rise of nitrous oxide in toxicological casework: no laughing matter. D'Orazio A.L., Bierly J.J., Midthun K.M., art. bkaf108.
- 4-Anilino-N-phenylethylpiperidine (4-ANPP): the potential caution flag for illicit fentanyl. Laraia N., Bierly J.J., Chan-Hosokawa A., art. bkaf111.
- Validation of a microsampling-compatible liquid–liquid extraction method for cannabinoid quantitation in 50 µL of whole blood using liquid chromatography–mass spectrometry. Mohammed A.A., Khan M., Chan H., Brubacher J.R., art. bkag004.
Cote :
Abonnement numérique
Dépouillements
Ajouter le résultat à votre sélection
Nouveauté
A. L. D'ORAZIO ;
J. J. BIERLY ;
K. M. MIDTHUN
|
2026
Dans Journal of Analytical Toxicology (Vol.50, n°3, March 2026) Article : Périodique
Dans Journal of Analytical Toxicology (Vol.50, n°3, March 2026) Article : Périodique
Nitrous oxide (N2O), the colorless, odorless gas known as "laughing gas," has gained recent attention for its misuse as a recreational drug. As an anesthetic, N2O produces sedation, euphoric, and possible hallucinogenic effects. Adverse effects [...]